Search
Filter by categories
Total number of items: 930
CAR T cells – the first clinical trial in Europe
Uppsala University and Uppsala University Hospital are pioneers in CAR T treatment. Uppsala University and Uppsala University Hospital were in 2014 the first in Europe to treat cancer patients
Placenta-derived stromal cells in severe acute GvHD
Mats Remberger, adjunct professor at the Department of Medical Sciences, Hematology, is working on a method to treat acute GvHD with placenta-derived stromal cells (DSC). Acute graft versus host
What are advanced therapy medicinal products (ATMPs)?
Advanced therapy medicinal products are based on living materials such as cells, tissues or genes and constitute a separate class of medicines that are subject to their own regulatory framework.
AdVince - immunotherapy for neuroendocrine cancer
AdVince is an immunotherapy developed by Professor Magnus Essand's research group at Uppsala University. It is a so-called oncolytic adenovirus that is used in the treatment of neuroendocrine